Patent · US Active

Crystalline 19-nor C3,3-disubstituted C21-n-pyrazolyl steroid

US11884696B2 · kind B2 · utility

1Cited by
8References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 6, 2021
Grant dateJan 30, 2024
Priority date
Expiry dateDec 7, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/13
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention relates to a crystalline 19-nor C3,3-disubstituted C21-pyrazolyl steroid of Formula (I), and compositions thereof. Also disclosed herein are methods of making the same and methods of using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.